Statin-induced myopathy could be justified genetically in certain cases, based on previous findings from the SEARCH genome-wide association study which has identified a SNP in the SLCO1B1 gene as a potential risk factor (Stewart, 2013). Here, SLCO1B1 is linked to myopathy.